Literature DB >> 8010724

Malignant tumors in the head of the pancreas and the periampullary region. Diagnostic and prognostic aspects.

F Griffanti-Bartoli1, G B Arnone, P Ceppa, G Ravera, S Carrabetta, D Civalleri.   

Abstract

This paper analyzes the value of ultrasonography (US), computerized tomography (CT) and endoscopic retrograde cholangiopancreatography (ERCP) to establish the location, nature and resectability of carcinomas of the pancreatic head and of the periampullary region. The prognostic importance of certain pathological factors in relation to survival was also evaluated. As regards the site of origin, 112 cases with carcinoma were classified as follows: 56 pancreatic, 32 ampullary, 10 common bile duct, and 14 undefined. Papillary tumors were more accurately defined by ERCP compared to CT+US (p = 0.033), whereas CT was less accurate than US+ERCP (p = 0.05). No significant differences were found in pancreatic and common bile duct tumors. Pathological confirmation was obtained with ERCP in 54 cases (46% pancreatic, 69% papillary and 50% common bile duct). In the remaining 58 patients (including 1 chronic pancreatitis) the diagnosis was confirmed with percutaneous or intraoperative biopsy. Tumor extent was better defined by US+CT. In 42 resected patients the final pathological examination revealed an error of preoperative staging in 79% pancreatic, 59% papillary, and 83% common bile duct tumors. Tumor size, nodal status, perivascular, capsular and portal vein infiltration proved to be significant prognostic factors for pancreatic tumors. Stepwise regression identified tumor size, capsular infiltration and perivascular invasion as the most important covariates for survival. Ulceration, papillary histotype, pancreas and Oddi muscle infiltration, grading, perineural, lymphatic and vascular involvement were found to be significant in papillary tumors. The Cox proportional hazard model showed that pancreatic, Oddi muscle, perineural infiltration, and histologic type respectively represent a relative risk of 5.93, 107.36, 21.31, 20.61. The limited number of cases of common bile duct primary did not allow us to carry out statistical analysis on these tumors.

Entities:  

Mesh:

Year:  1994        PMID: 8010724

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.

Authors:  De-shen Wang; Hui-yan Luo; Miao-zhen Qiu; Zhi-qiang Wang; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  Med Oncol       Date:  2012-04-05       Impact factor: 3.064

3.  Pre-treatment neutrophil to lymphocyte ratio as a predictive marker for pathological response to preoperative chemoradiotherapy in pancreatic cancer.

Authors:  Shinichiro Hasegawa; Hidetoshi Eguchi; Akira Tomokuni; Yoshito Tomimaru; Tadafumi Asaoka; Hiroshi Wada; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masamitsu Konnno; Hideshi Ishii; Masaki Mori; Yuichiro Doki; Hiroaki Nagano
Journal:  Oncol Lett       Date:  2015-12-24       Impact factor: 2.967

4.  An audit of pathology lymph node dissection techniques in pylorus preserving Kausch-Whipple pancreatoduodenectomy specimens.

Authors:  I H Chaudhry; F Campbell
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

5.  Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas.

Authors:  N B Jamieson; P Glen; D C McMillan; C J McKay; A K Foulis; R Carter; C W Imrie
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

6.  Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.

Authors:  J Szkandera; M Stotz; G Absenger; T Stojakovic; H Samonigg; P Kornprat; R Schaberl-Moser; W Alzoughbi; C Lackner; A L Ress; F S Seggewies; A Gerger; G Hoefler; M Pichler
Journal:  Br J Cancer       Date:  2013-11-07       Impact factor: 9.075

7.  External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.

Authors:  Joanna Szkandera; Michael Stotz; Florian Eisner; Gudrun Absenger; Tatjana Stojakovic; Hellmut Samonigg; Peter Kornprat; Renate Schaberl-Moser; Wael Alzoughbi; Anna Lena Ress; Friederike Sophia Seggewies; Armin Gerger; Gerald Hoefler; Martin Pichler
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.